CD8+ antigen-specific T cells
Drug timelines are a Plus or Pro feature.
1 regulatory and trial event tracked for CD8+ antigen-specific T cells, covering 2024-10-08 to 2024-10-08. Get the full timeline:
Most recent: Clinical Trial Update: CD8+ Antigen-Specific T Cells, Cyclophosphamide, Aldesleukin, and Ipilimumab in Treating Patients With Metastatic Melanoma [Phase 2]